Pasithea Therapeutics (KTTA) Free Cash Flow (2021 - 2024)
Historic Free Cash Flow for Pasithea Therapeutics (KTTA) over the last 4 years, with Q4 2024 value amounting to -$2.4 million.
- Pasithea Therapeutics' Free Cash Flow rose 2584.07% to -$2.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$13.9 million, marking a year-over-year decrease of 836.68%. This contributed to the annual value of -$13.9 million for FY2024, which is 836.68% down from last year.
- Latest data reveals that Pasithea Therapeutics reported Free Cash Flow of -$2.4 million as of Q4 2024, which was up 2584.07% from -$3.1 million recorded in Q3 2024.
- Over the past 5 years, Pasithea Therapeutics' Free Cash Flow peaked at -$381845.0 during Q1 2021, and registered a low of -$4.6 million during Q3 2022.
- For the 4-year period, Pasithea Therapeutics' Free Cash Flow averaged around -$2.6 million, with its median value being -$3.1 million (2023).
- Per our database at Business Quant, Pasithea Therapeutics' Free Cash Flow tumbled by 74367.72% in 2022 and then skyrocketed by 3051.37% in 2023.
- Quarter analysis of 4 years shows Pasithea Therapeutics' Free Cash Flow stood at -$1.8 million in 2021, then crashed by 86.55% to -$3.3 million in 2022, then dropped by 0.49% to -$3.3 million in 2023, then increased by 25.84% to -$2.4 million in 2024.
- Its last three reported values are -$2.4 million in Q4 2024, -$3.1 million for Q3 2024, and -$4.0 million during Q2 2024.